MedPath

Height anxiety study

Not Applicable
Conditions
F40.2
Specific (isolated) phobias
Registration Number
DRKS00008999
Lead Sponsor
ehrstuhl für Psychologie I, Universität Würzburg
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
36
Inclusion Criteria

Acrophobia; diagnosed specific phobia using the SCID-I

Exclusion Criteria

* Schizophrenia and other psychotic disorders
* Major depression
* Substance dependence
* Cardiovascular disease
* Pregnancy
* Nausea in 3D movies < 3 (on a 0-10 scale)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Acrophobia Questionnaire, at the beginning and the end of the study (2-3 days after the last exposure session), as well as a 6-month follow-up.
Secondary Outcome Measures
NameTimeMethod
Behavioral Avoidance Test (subjective fear ratings while climbing the staircase of a parking lot), at the beginning and the end of the study (2-3 days after the last exposure session).
© Copyright 2025. All Rights Reserved by MedPath